Primary and challenge infection of mice with equine herpesvirus 1, strain HSV25A.

[1]  J. Gilkerson,et al.  Immune responses and protective efficacy of recombinant baculovirus-expressed glycoproteins of equine herpesvirus 1 (EHV-1) gB, gC and gD alone or in combinations in BALB/c mice. , 1998, Veterinary microbiology.

[2]  R. A. Killington,et al.  High level expression of equine herpesvirus 1 glycoproteins D and H and their role in protection against virus challenge in the C3H (H-2Kk) murine model. , 1997, Virus research.

[3]  K. R. Marshall,et al.  An equine herpesvirus-1 gene 71 deletant is attenuated and elicits a protective immune response in mice. , 1997, Virology.

[4]  R. A. Killington,et al.  The production of a truncated form of baculovirus expressed EHV-1 glycoprotein C and its role in protection of C3H (H-2Kk) mice against virus challenge. , 1996, Virus research.

[5]  S. Jennings,et al.  Equine herpesvirus-1 strain KyA, a candidate vaccine strain, reduces viral titers in mice challenged with a pathogenic strain, RacL. , 1996, Virus research.

[6]  H. Field,et al.  Molecular studies of the acute infection, latency and reactivation of equine herpesvirus-1 (EHV-1) in the mouse model. , 1996, Virus research.

[7]  R. A. Killington,et al.  Role of T-cells, virus neutralising antibodies and complement-mediated antibody lysis in the immune response against equine herpesvirus type-1 (EHV-1) infection of C3H (H-2k) and BALB/c (H-2d) mice. , 1995, Research in veterinary science.

[8]  P. Canfield,et al.  Analysis of feline dual lymphocyte populations observed by flow cytometry. , 1995, Veterinary immunology and immunopathology.

[9]  D. Goovaerts,et al.  A mouse model for testing the pathogenicity of equine herpes virus-1 strains. , 1995, Journal of virological methods.

[10]  R. Wagner,et al.  Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). , 1995, Virology.

[11]  D. Love,et al.  Equine herpesvirus 1 HVS25A isolated from an aborted foetus produces disease in balb/C mice. , 1995, Australian veterinary journal.

[12]  B. Crabb,et al.  Equine herpesviruses 4 (equine rhinopneumonitis virus) and 1 (equine abortion virus). , 1995, Advances in virus research.

[13]  D. Love,et al.  Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model. , 1994, The Journal of general virology.

[14]  D. Boyle,et al.  Expression of equine herpesvirus 1 glycoprotein D by using a recombinant baculovirus , 1993, Journal of virology.

[15]  J. McCulloch,et al.  The effect of EHV-1 infection upon circulating leucocyte populations in the natural equine host. , 1993, Veterinary microbiology.

[16]  H. Field,et al.  Pathogenicity of a thymidine kinase-deficient mutant of equine herpesvirus 1 in mice and specific pathogen-free foals. , 1993, The Journal of general virology.

[17]  N. Edington,et al.  Immunoprecipitation of viral polypeptides of equid herpesvirus 1 and 4 by serum from experimentally infected ponies. , 1993, Veterinary microbiology.

[18]  H. Iwai,et al.  Equid herpesvirus 1 infection in mice. , 1993, The Journal of veterinary medical science.

[19]  W. Duffus,et al.  Immune responses of specific pathogen free foals to EHV-1 infection. , 1992, Veterinary microbiology.

[20]  H. Field,et al.  Serological responses of specific pathogen-free foals to equine herpesvirus-1: primary and secondary infection, and reactivation. , 1992, Veterinary microbiology.

[21]  D. Love,et al.  Characterization of the glycoprotein D gene products of equine herpesvirus 1 using a prokaryotic cell expression vector. , 1992, Veterinary microbiology.

[22]  A. Awan,et al.  A murine model for studying EHV-1-induced abortion. , 1991, Research in veterinary science.

[23]  B. Crabb,et al.  Comparative studies of the proteins of equine herpesviruses 4 and 1 and asinine herpesvirus 3: antibody response of the natural hosts. , 1990, The Journal of general virology.

[24]  A. Awan,et al.  The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection. , 1990, The Journal of general virology.

[25]  M. Studdert,et al.  Latency of equine herpesvirus 4 , 1989, The Veterinary Record.

[26]  G. Allen,et al.  Use of lambda gt11 and monoclonal antibodies to map the genes for the six major glycoproteins of equine herpesvirus 1 , 1987, Journal of virology.

[27]  A. Wrathall,et al.  Efficacy of porcine parvovirus vaccines , 1986, Veterinary Record.

[28]  Bryans Jt,et al.  Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. , 1986 .

[29]  Scott Jc,et al.  In vivo harboring of equine herpesvirus-1 in leukocyte populations and subpopulations and their quantitation from experimentally infected ponies. , 1983 .

[30]  Dutta Sk,et al.  Lymphocytes from ponies experimentally infected with equine herpesvirus 1: subpopulation dynamics and their response to mitogens. , 1982 .

[31]  J. M. Whalley,et al.  Differentiation of sub-types of equine herpesvirus I by restriction endonuclease analysis. , 1981, Australian veterinary journal.

[32]  Dutta Sk,et al.  Lymphocyte responses to virus and mitogen in ponies during experimental infection with equine herpesvirus 1. , 1980 .

[33]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .